Fetal MRI for Body and Placental Assessment

Fetal magnetic resonance imaging has developed from a problem-solving examination into an important part of specialist prenatal care. Although brain imaging remains its most familiar application, MRI can also clarify abnormalities in the chest, abdomen, urinary tract, skeleton, airway, and placenta when ultrasound findings are incomplete or difficult to interpret.

The subject, Fetal MRI for Non-Brain Indications: Body and Placenta, is especially relevant to perinatal teams managing complex referrals. A carefully planned examination can improve diagnostic confidence, support parental counseling, and help neonatal specialists prepare for delivery and immediate postnatal treatment.

MRI does not use ionizing radiation, and modern fetal protocols can acquire useful images during relatively short periods of maternal breath-holding or fetal stillness. It is not a replacement for expert ultrasound. Rather, it adds tissue contrast, a wider field of view, and anatomical information that may be obscured by maternal habitus, oligohydramnios, fetal position, or late gestational age.

Why Fetal MRI Extends Beyond the Brain

Ultrasound is usually the first-line examination because it is accessible, dynamic, and capable of assessing fetal movement, blood flow, and cardiac activity. MRI becomes valuable when ultrasound raises a question that could influence prognosis or delivery planning but cannot answer with sufficient certainty. The scan may confirm an abnormality, reveal its full extent, or demonstrate that a suspected lesion is less severe than initially thought.

Non-neurological referrals commonly involve congenital diaphragmatic hernia, thoracic masses, pulmonary airway malformations, abdominal cysts, renal anomalies, pelvic lesions, skeletal dysplasia, and suspected placental disease. MRI can show relationships between a lesion and nearby organs, vessels, or the diaphragm. This anatomical overview is often essential when clinicians are deciding whether a fetus should be delivered at a tertiary center.

The examination also contributes to a more precise conversation with parents. A broad ultrasound description such as “complex abdominal mass” may become a more specific assessment of organ of origin, cystic or solid composition, and likely postnatal implications. Such clarity helps families understand why delivery location, neonatal surgery, respiratory support, or additional testing may be recommended.

Selecting Cases and Preparing the Examination

Referral should be based on a clinical question rather than a desire to obtain more images. The requesting team should explain what ultrasound has shown, what remains uncertain, and how the MRI result could change management. This approach prevents unnecessary examinations and helps the radiologist tailor the protocol to the suspected condition.

The scan is generally performed without sedation. The mother is positioned comfortably, often in a left-tilted or lateral posture when needed, with attention to temperature, communication, and the ability to stop the examination. Fast single-shot T2-weighted sequences provide the core anatomical information. T1-weighted imaging, diffusion-weighted imaging, balanced steady-state sequences, or cine acquisitions can be added for specific questions.

Maternal screening should address implanted devices, metallic fragments, prior surgery, and the clinical condition of the pregnancy. Gadolinium contrast is generally avoided during pregnancy because its fetal safety profile is not sufficiently established for routine use. Image quality depends on minimizing motion, selecting an appropriate field of view, and acquiring repeated sequences when fetal movement interrupts the first attempt.

Reading the Fetal Chest and Abdomen

Thoracic MRI is particularly helpful when a lung lesion, diaphragmatic defect, or mediastinal mass affects the position and development of the heart and lungs. MRI can identify the extent of herniated liver or bowel, estimate the remaining functional lung volume, and show whether a mass compresses the airway or major vessels. These findings may support decisions about delivery in a center equipped for advanced respiratory stabilization.

For pulmonary lesions, signal characteristics and lesion volume can complement ultrasound and help distinguish macrocystic from predominantly microcystic disease. MRI may also show fluid-filled airways, abnormal lung development, and the effect of a lesion on the contralateral lung. However, predicted postnatal respiratory function should not be based on a single imaging measurement; gestational age, lesion evolution, hydrops, and clinical findings remain important.

Abdominal MRI can clarify the origin of cystic or solid masses and identify whether the liver, bowel, kidneys, bladder, or pelvis is involved. It can demonstrate bowel dilatation, meconium-related signal changes, urinary tract obstruction, renal parenchymal abnormalities, and the consequences of severe bladder enlargement. In suspected anorectal or cloacal malformations, the wider anatomical view may provide information that is difficult to obtain sonographically.

Understanding Placental Imaging

The placenta is a major non-brain target for fetal MRI, particularly when ultrasound suggests abnormal invasion, unusual thickness, hematoma, or a mass. MRI can assess the placenta in relation to the myometrium, cervix, bladder, and other pelvic structures. This is especially important when placenta previa coexists with a history of cesarean delivery, raising concern for placenta accreta spectrum.

Placental MRI findings must be interpreted cautiously. Dark intraplacental bands, heterogeneous signal, uterine bulging, and abnormal vascularity can support suspicion, but none is perfectly specific. Normal variations in placental appearance, maternal motion, contractions, and differences in scanner technique may produce misleading features. MRI should therefore complement expert ultrasound and multidisciplinary review rather than replace them.

In placental masses, MRI may distinguish a vascular tumor such as chorioangioma from hemorrhage or other tissue abnormalities. The size, location, internal composition, and relationship to the fetal surface can influence surveillance. A large or highly vascular lesion may be associated with fetal anemia, hydrops, polyhydramnios, or cardiac strain, making serial assessment more important than a single static diagnosis.

Linking Imaging to Perinatal Management

The value of fetal MRI lies in how its findings connect with obstetric, neonatal, surgical, anesthetic, and genetic expertise. A report should state the indication, gestational age, technique, image limitations, key anatomical findings, and degree of diagnostic confidence. It should also explain clinically relevant consequences rather than simply list signal patterns.

For example, a report on suspected diaphragmatic hernia should describe the side of the defect, the organs in the chest, the position of the heart, and the appearance of the remaining lungs. A placental report should address location, uterine scars, the bladder interface, suspicious vascularity, and whether the findings strengthen or weaken concern for invasive placentation.

Communication is particularly important when MRI changes the anticipated pathway. Findings may prompt referral to fetal therapy, delivery at a surgical center, planned neonatal airway management, blood-product preparation, or postnatal echocardiography. Perinatal conferences are useful because the same image can have different implications for obstetrics, neonatology, radiology, and pediatric surgery.

Neonatal planning should extend beyond anatomy. A fetus with thoracic compression may require respiratory support, while a fetus with placental complications may face anemia, prematurity, or hemodynamic instability. Practical neonatal preparation, including oxygen assessment and careful adjustment of respiratory support, can be informed by wider perinatal guidance such as neonatal oxygen therapy.

Avoiding Common Interpretive Errors

Motion is the most frequent technical limitation. Blurred images can obscure small vessels, the airway, or the placental-myometrial interface. Repeating a sequence may help, but repeated acquisitions do not always solve the problem. Radiologists should distinguish a true abnormality from an artifact and state when image quality limits confidence.

Another error is treating MRI measurements as absolute predictors. Lung volume estimates, placental thickness, and lesion dimensions are affected by gestational age, segmentation choices, fetal position, and scanner settings. Trends over time may be more informative than isolated numbers, especially for evolving lung lesions or placental tumors.

MRI can also create false reassurance. A normal-appearing structure does not exclude functional impairment, microscopic disease, chromosomal abnormalities, or complications that develop later. Conversely, an unusual signal pattern does not automatically indicate severe disease. Correlation with ultrasound, Doppler studies, maternal history, laboratory results, and genetic testing remains essential.

Practical Reporting Priorities

• State the clinical question and identify the main diagnostic uncertainty.
• Describe lesion location, organ relationships, composition, and effects on nearby structures.
• Include gestational age, relevant measurements, and limitations caused by motion or incomplete sequences.
• Separate observed findings from interpretation and clearly identify features that affect delivery planning.
• Recommend multidisciplinary review when the result may alter fetal therapy, delivery location, or neonatal treatment.

Building a Reliable Imaging Pathway

A consistent institutional pathway improves the usefulness of fetal MRI. Referrals should include recent ultrasound images and reports, maternal surgical history, gestational age, suspected diagnosis, and the management decision that depends on the scan. Radiology, maternal-fetal medicine, neonatology, and pediatric surgery should agree on urgent referral criteria and reporting standards.

Training should cover more than image acquisition. Teams need experience recognizing normal fetal anatomy outside the brain, understanding gestational changes, evaluating placental interfaces, and discussing uncertainty. Audit of image quality, diagnostic changes after MRI, delivery-site decisions, and postnatal correlation can reveal where the service adds value and where protocols need refinement.

The wider perinatal setting also matters. The FAOPS 2020 congress, held with PREBIC AA 2020 in Tokyo before its cancellation during the COVID-19 pandemic, represented the kind of international scientific exchange that advances fetal and neonatal practice; its FAOPS 2020 congress site preserves that meeting’s focus on perinatal medicine, research, and collaboration.

Fetal MRI for body and placental indications is most effective when it answers a defined question and feeds directly into coordinated care. Clinicians can strengthen that pathway by reviewing local protocols, discussing representative cases at multidisciplinary meetings, and correlating prenatal images with neonatal findings. Use each examination to make delivery safer, counseling clearer, and postnatal treatment more prepared.